-
-
-
-
-
-
-
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
-
-
-
-
-
-
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
-
-
-
-
-
-
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
-
-
-
-
-
-
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
-
-
-
-
-
-
Jefferies reiterates Buy on GeneDx (WGS) as analyst dismisses TAM saturation fears
-
-
-
-
-
-
-
Wells Fargo Upgrades GeneDx (WGS) to Overweight
-
-
-
-
-
-
-
GeneDx (WGS) PT Raised to $165 at BTIG
-
435,588 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

